Logo image
Back
Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens
Journal article   Open access   Peer reviewed

Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens

Pedro Rada, Jessica R. Barson, Sarah F. Leibowitz and Bartley G. Hoebel
Brain research, v 1312, pp 1-9
2010
DOI: https://doi.org/10.1016/j.brainres.2009.11.055
PMID: 19948154
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://europepmc.org/articles/pmc2824171View
Accepted (AM)Open Access (License Unspecified),  Open

Abstract

DALA DAMGO Hypothalamus Morphine Naloxone Nucleus accumbens
The experimental question is whether hypothalamic opioids, known to stimulate consummatory behavior, control a link to the nucleus accumbens (NAc). It was hypothesized that opioids injected in the hypothalamic paraventricular nucleus (PVN) alter the balance of dopamine (DA) and acetylcholine (ACh) in the NAc in a manner that fosters appetite for food or ethanol. Rats were implanted with two guide shafts, one in the NAc to measure extracellular DA and ACh by microdialysis and the other in the PVN for microinjection of opioid μ- and δ-agonists, an antagonist, or saline vehicle. The compounds tested were morphine, the μ-receptor agonist [ d-Ala 2,N-Me-Phe 4,Gly 5-ol]-Enkephalin (DAMGO), the δ-receptor agonist d-Ala-Gly-Phe-Met-NH2 (DALA), and the opioid antagonist naloxone methiodide (m-naloxone). Morphine in the PVN increased the release of accumbens DA (+ 41%) and decreased ACh (− 35%). Consistent with this, the opioid antagonist m-naloxone decreased DA (− 24%) and increased ACh (+ 19%). In terms of receptor involvement, DAMGO dose-dependently increased DA to up to 209% of baseline. Simultaneously, ACh levels were markedly decreased to 55% of baseline. The agonist DALA produced a smaller but significant, 34% increase in DA, without affecting ACh. In contrast, control injections of saline had no significant effect. These results demonstrate that μ- and δ-opioids in the PVN contribute to the control of accumbens DA and ACh release and suggest that this circuit from the PVN to the NAc may be one of the mechanisms underlying opiate-induced ingestive behavior as well as naltrexone therapy for overeating and alcoholism.

Metrics

5 Record Views
43 citations in Web of Science
44 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Neurosciences
Logo image